63. 特発性血小板減少性紫斑病 Idiopathic thrombocytopenic purpura Clinical trials / Disease details

臨床試験数 : 391 / 薬物数 : 235 - (DrugBank : 50) / 標的遺伝子数 : 49 - 標的パスウェイ数 : 139

2 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03692754 (ClinicalTrials.gov)	November 1, 2021	29/9/2018	Atorvastatin in Management of Newly Diagnosed ITP	A Single-center Prospective Randomized Study of Atorvastatin in the Treatment of Newly Diagnosed Primary Immune Thrombocytopenia (ITP)	Immune Thrombocytopenia;Purpura, Thrombocytopenic	Drug: Atorvastatin 20mg;Drug: Atorvastatin 10mg;Drug: Dexamethasone	Shandong University	NULL	Not yet recruiting	18 Years	80 Years	All	30	Phase 2/Phase 3	China
2	NCT05551624 (ClinicalTrials.gov)	July 4, 2018	20/9/2022	Evaluation of the Effect in Platelet Count of Atorvastatin and N-acetyl Cysteine	Evaluation of the Effect in Platelet Count of Atorvastatin and N-acetyl Cysteine in Patients With Primary Immune Thrombocytopenia Resistant to Steroid Treatment or in Relapse: An Exploratory Clinical Trial	Primary Immune Thrombocytopenia	Drug: Atorvastatin 40 Mg Oral Tablet + N-acetylcysteine 400 mg Oral tablet	Hospital Civil de Guadalajara	NULL	Completed	15 Years	N/A	All	15	Early Phase 1	Mexico